Chronic hepatitis C

2 trials MedDRA PT
2 Registered trials
0 Recruiting
1 Unique sponsors
4 Unique IMPs
2 Commercial trials
Drug classes (ATC)
J Anti-infectives (ATC J) 1
— ATC code not specified 1
Mechanism of action (INN-stem analysis)
Antiviral 2 substances
Unknown / small molecule 2 substances
Phase III: 1 Phase II: 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase III

1 trial
  • Atea Pharmaceuticals Inc. Commercial
    RUZASVIR, BEMNIFOSBUVIR; SOFOSBUVIR, VELPATASVIR
    2025-521096-31-00 6 countries 2025 n=275
    Ended

Phase II

1 trial
  • Atea Pharmaceuticals Inc. Commercial
    BEMNIFOSBUVIR HEMISULFATE; RUZASVIR
    2023-504566-28-00 3 countries 2023 n=39
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Atea Pharmaceuticals Inc. Commercial 2 Phase II, Phase III 0
New trials by year
2023
1
2025
1
← All indication landscapes